Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
about
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@en
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@nl
type
label
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@en
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@nl
prefLabel
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@en
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@nl
P2093
P2860
P1433
P1476
Distinct transcriptional chang ...... NActive® CV9201 immunotherapy.
@en
P2093
Andreas Schröder
Birgit Scheel
Henoch S Hong
Ingmar Hoerr
James M Billingsley
Karl-Josef Kallen
Linus Backert
Mariola Fotin-Mleczek
Oliver Kohlbacher
Sven D Koch
P2860
P304
P356
10.1080/2162402X.2016.1249560
P577
2016-11-18T00:00:00Z